A survey of clusterin and fascin expression in sarcomas and spindle cell neoplasms: strong clusterin immunostaining is highly specific for follicular dendritic cell tumor
- 1 February 2005
- journal article
- research article
- Published by Elsevier BV in Laboratory Investigation
- Vol. 18 (2), 260-266
- https://doi.org/10.1038/modpathol.3800294
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Clusterin Expression Distinguishes Follicular Dendritic Cell Tumors From Other Dendritic Cell NeoplasmsThe American Journal of Surgical Pathology, 2004
- Clusterin, a Marker for Anaplastic Large Cell LymphomaAmerican Journal of Clinical Pathology, 2004
- Clusterin Is Widely Expressed in Systemic Anaplastic Large Cell Lymphoma but Fails to Differentiate Primary From Secondary Cutaneous Anaplastic Large Cell LymphomaAmerican Journal of Clinical Pathology, 2002
- Clusterin Expression in Malignant Lymphomas: A Survey of 266 CasesLaboratory Investigation, 2002
- Langerhans Cell HistiocytosisAmerican Journal of Clinical Pathology, 2002
- ClusterinThe International Journal of Biochemistry & Cell Biology, 2002
- Extranodal Follicular Dendritic Cell Sarcoma of the Head and Neck Region: Three New Cases, with a Review of the LiteratureLaboratory Investigation, 2002
- Inflammatory Pseudotumor-Like Follicular Dendritic Cell TumorThe American Journal of Surgical Pathology, 2001
- The role of complement in the acquired immune responseImmunology, 2000
- Distinct sites of production and deposition of the putative cell death marker clusterin in the human thymus.JCI Insight, 1992